Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11796179rdf:typepubmed:Citationlld:pubmed
pubmed-article:11796179lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0007578lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0020456lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0683149lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C0542560lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:11796179lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:11796179pubmed:issue2lld:pubmed
pubmed-article:11796179pubmed:dateCreated2002-1-17lld:pubmed
pubmed-article:11796179pubmed:abstractTextTo investigate the relationships between serum concentrations of soluble adhesion molecules and hyperglycemia, insulin resistance, or other conventional risk factors in type 2 diabetes, we measured soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-selectin), insulin sensitivity, and conventional risk factors in 150 Japanese type 2 diabetic patients without apparent diabetic macroangiopathy. High serum concentrations of sVCAM-1 and sE-selectin were observed in patients with type 2 diabetes. Serum concentrations of soluble adhesion molecules were not significantly influenced by sex, hypertension, dyslipidemia, or microangiopathy. Spearman correlation showed that sVCAM-1 concentrations correlated significantly with fasting plasma glucose (FPG), fasting C-peptide, and insulin sensitivity [K index of the insulin tolerance test (K(ITT))] (rho=0.19,0.23, and -0.23, respectively). Soluble E-selectin concentrations correlated significantly with body mass index (BMI), FPG, fasting C-peptide, insulin sensitivity, and triglyceride (rho=0.33,0.42,0.26,-0.48, and 0.29, respectively). Multiple regression analysis showed that FPG, fasting C-peptide, and total cholesterol were independent factors that correlated with sVCAM-1 levels. BMI, FPG, and insulin sensitivity were independent factors that correlated with sE-selectin levels. Serum concentrations of sE-selectin significantly increased associated with clustering of conventional risk factors those obesity, hypertension, dyslipidemia, and current smoking (P<0.01). Thus, sVCAM-1 and sE-selectin levels are related to both hyperglycemia and insulin resistance. Soluble E-selectin levels may be related to obesity, hyperglycemia, and insulin resistance and may reflect the presence of a multiple risk factor clustering syndrome.lld:pubmed
pubmed-article:11796179pubmed:languageenglld:pubmed
pubmed-article:11796179pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:citationSubsetIMlld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11796179pubmed:statusMEDLINElld:pubmed
pubmed-article:11796179pubmed:monthFeblld:pubmed
pubmed-article:11796179pubmed:issn0168-8227lld:pubmed
pubmed-article:11796179pubmed:authorpubmed-author:MatsumotoKazu...lld:pubmed
pubmed-article:11796179pubmed:authorpubmed-author:SeraYasunoriYlld:pubmed
pubmed-article:11796179pubmed:authorpubmed-author:NakamuraHidek...lld:pubmed
pubmed-article:11796179pubmed:authorpubmed-author:UekiYukitakaYlld:pubmed
pubmed-article:11796179pubmed:authorpubmed-author:MiyakeSeibeiSlld:pubmed
pubmed-article:11796179pubmed:issnTypePrintlld:pubmed
pubmed-article:11796179pubmed:volume55lld:pubmed
pubmed-article:11796179pubmed:ownerNLMlld:pubmed
pubmed-article:11796179pubmed:authorsCompleteYlld:pubmed
pubmed-article:11796179pubmed:pagination131-8lld:pubmed
pubmed-article:11796179pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:meshHeadingpubmed-meshheading:11796179...lld:pubmed
pubmed-article:11796179pubmed:year2002lld:pubmed
pubmed-article:11796179pubmed:articleTitleSerum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus.lld:pubmed
pubmed-article:11796179pubmed:affiliationDepartment of Diabetes and Metabolism, Sasebo Chuo Hospital, 15 Yamato-cho, Sasebo, Nagasaki 857-1195, Japan.lld:pubmed
pubmed-article:11796179pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11796179lld:pubmed